| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
818 |
667 |
$48K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
34 |
14 |
$12K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
86 |
74 |
$7K |
| 96127 |
|
302 |
271 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
82 |
78 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
59 |
58 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
49 |
36 |
$3K |
| 87631 |
|
30 |
30 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
17 |
12 |
$2K |
| 96160 |
|
107 |
100 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
54 |
51 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
52 |
35 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
30 |
30 |
$2K |
| 90656 |
|
65 |
65 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
41 |
29 |
$961.86 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
62 |
33 |
$910.60 |
| 90686 |
|
54 |
31 |
$860.84 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
15 |
13 |
$491.26 |
| 90698 |
|
16 |
13 |
$267.36 |
| 90651 |
|
13 |
13 |
$217.23 |
| 90619 |
|
12 |
12 |
$200.52 |
| 99173 |
|
26 |
26 |
$186.25 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$117.26 |